Pedro Ochoa-Allemant
@OchoaAllemantMD
Followers
879
Following
3K
Statuses
2K
GI Fellow @Penn via @YaleIMed & @USMP_oficial | Interested in preventing the development/progression of steatotic liver disease in at-risk populations | Peruano
Philadelphia, PA
Joined April 2009
RT @NoureddinMD: What a day in the history of MASH! Reversal of Fibrosis in MASH cirrhotics by 24% (paired) and 17% (ITT) all sig P values.…
0
46
0
RT @mezzacappa_c: To research outcomes and implement trials for different SLD subtypes, we need to be able to accurately identify each clin…
0
10
0
1
0
1
1
0
1
Well-deserved @jemedinaMD ! Y gracias @BonderAlan for believing in us since day 1!
Excited to share that yet another former fellow from our @IRiScience autoimmune lab is heading to a GI powerhouse! Huge congrats to Esli on this well-deserved achievement. Remember to pay it forward and inspire the next generation of scientists! #IRiFellows #Gastroenterology #Mentorship 💡🔬💪@jemedinaMD @dgoyesv @OchoaAllemantMD
0
0
4
RT @jmarrero6713: Excited about these incoming ⭐️s to our GI fellowship program! The future is certainly bright. @penngihep @AmCollegeGastr…
0
14
0
RT @RomeliaBarba: Three generations of Emerging Liver Scholar together, #TLM24 made it happen. Thanks @AASLDFoundation for your support of…
0
8
0
0
7
0
Another drug showing an improvement in steatohepatitis and fibrosis coming to the US soon for patients with MASLD!
Breaking news. Sema hits both points for MASH resolution and Fibrosis improvement in the Ph 3 study! 62.9% vs 34.1% and 37% vs 22.5% respectively . Waiting to see F3, F2, titration and tolerance and drop out at #TLM24 #livertwitter @schattenbergJ @AlkhouriNaim @DrLoomba @EASLedu @AASLDtweets #GLP1
0
1
7
RT @ebtapper: How to resmetirom Practice guidelines from @AASLDtweets led by @MichiganLiver’s own Vincent Chen Open access: https://t.co/…
0
74
0
2 days of intense research brainstorming for grants and studies to improve the care of patients with liver disease #VOCAL #PennYaleMiami
@mezzacappa_c @RabieeAnahita @serperm @KaplanDeLiver #TamarTaddei @docbinujohn @ggarciatsao
0
4
31
RT @BonderAlan: Representation matters, especially in the medical field. We need more Latino physicians, and today, we celebrate the Nation…
0
16
0
Rewarding and inspiring long weekend in DC participating in the @AmerGastroAssn #AdvocacyDay and the #LeadershipSummit with the #FORWARDFamily
0
0
15
RT @juanpabloarab: Are you interested in MetALD? Please check out this @AASLDtweets Emerging Topic Conference 2025: MASLD, MetALD and ALD:…
0
20
0
RT @cjketc2: New study just dropped!! Knowledge about non-EoE EGIDs and overlap with EoE is limited. Looks like age and locations of invol…
0
1
0
RT @DrJavierCrespo: ¡Buenas noticias para la salud hepática! Los agonistas de #GLP1 no solo controlan la diabetes, también podrían preveni…
0
50
0
RT @jemedinaMD: Just recently published at @LiverInt , our work on waitlist outcomes and post-transplant outcomes in MASLD/AIH. We found b…
0
6
0
1
0
2